CML

H Alkhatabi1, S Aldahlawi, M S Hazzazi

  • 1Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. eyasin@kau.edu.sa.

概括

全转录组测序揭示了慢性髓性白血病 (CML) 患者的显著基因表达差异,确定了与氨酸激酶抑制剂 (TKI) 耐药性相关的途径. 这些发现为CML治疗提供了新的治疗点.